GlassScriptPhysician profile
Luis C Ortiz
NPI 1295280386
$38,045.56
in general payments reported to CMS, 2019-2025
28 companies · $33K in 2025
The $33K reported for 2025 was more than what 94% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.48 · 2020: $142 · 2021: $37.84 · 2022: $170 · 2023: $745 · 2024: $3,838 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,499 · Food and Beverage: $9,272 · Consulting Fee: $4,500 · Travel and Lodging: $3,434 · Education: $27.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,950.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,499.00 |
| Food and Beverage | $9,272.43 |
| Consulting Fee | $4,500.00 |
| Travel and Lodging | $3,434.29 |
| Education | $27.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,881.81 | 2024-2025 | Freestyle Libre 3 |
| Insulet Corporation | $13,487.82 | 2023-2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $1,864.33 | 2022-2025 | Ozempic, Wegovy |
| Amgen INC. | $1,044.21 | 2023-2025 | Evenity, Tepezza, Prolia |
| Medtronic, INC. | $813.51 | 2022-2025 | Minimed 780g, Signia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $487.87 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $392.00 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $275.04 | 2024 | Farxiga |
| Beta Bionics, INC. | $209.96 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Corcept Therapeutics | $208.72 | 2024-2025 | Korlym |
| Radius Health, INC. | $178.22 | 2024-2025 | Tymlos |
| Neurocrine Biosciences, INC. | $139.29 | 2025 | |
| Inspire Medical Systems, INC. | $131.84 | 2023-2025 | Inspire |
| Nevro Corp. | $130.20 | 2024 | Senza |
| Boston Scientific Corporation | $125.13 | 2024 | Embold Fibered |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $106.60 | 2024 | |
| Janssen Pharmaceuticals, INC | $103.64 | 2020-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $90.63 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $83.37 | 2025 | Evkeeza |
| Abbvie INC. | $71.11 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.82 | 2024 | |
| Alexion Pharmaceuticals, INC. | $49.40 | 2025 | Strensiq |
| Tandem Diabetes Care, INC. | $22.94 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $22.84 | 2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $18.39 | 2024 | Recorlev |
| Ascendis Pharma Endocrinology INC | $17.85 | 2025 | Yorvipath |
| Esperion Therapeutics, INC. | $17.54 | 2025 | Nexletol |
| Pfizer INC. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.